270 top medical experts on Ornithine Carbamoyltransferase Deficiency Disease across 37 countries and 21 U.S. states, including 113 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Ornithine Carbamoyltransferase Deficiency Disease: An inherited urea cycle disorder associated with deficiency of the enzyme ornithine carbamoyltransferase, transmitted as an X-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Inborn Urea Cycle Disorders (1,187), X-Linked Genetic Diseases (2,304).
  4. Clinical Trials ClinicalTrials.gov : at least 20 including 1 Active, 8 Completed, 5 Recruiting
  5. Synonyms: OTC Deficiency,  Ornithine Transcarbamylase Deficiency,  Ornithine Transcarbamylase Deficiency Disease


  

        

                    


    Computing Expert Listing ...

);